Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, which still shows a 403 error. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study record continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe study page now renders a 403 Forbidden error page. This replaces the study details and navigation with an access-denied screen.SummaryDifference19%

- Check37 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, signaling a platform update. No study details or page content appear to be altered by this change.SummaryDifference0.1%

- Check51 days agoChange DetectedA new site revision number (v3.6.6) has been published, replacing the previous revision (v3.6.5).SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation or metadata. The visible study content and configuration appear unchanged.SummaryDifference0.1%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.